ResearcherKorea UniversityNo recent work listed
Hoon Jai Chun
Matched on ORCID iD 0000-0002-5539-361X; OpenAlex author ID A5072860238. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 15
2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers
Papers 5
- Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultrasonography but Indeterminate on Computed … Last author DOI 10.5009/gnl210123↗
- Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultrasonography but Indeterminate… Last author DOI 10.5009/gnl210123.e↗
- Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib. Co-author DOI 10.4251/wjgo.v8.i7.555↗
- Rare case of pancreatic cancer with leptomeningeal carcinomatosis. Co-author DOI 10.3748/wjg.v21.i3.1020↗
- Expression of heat shock protein 70 modulates the chemoresponsiveness of pancreatic cancer. Co-author DOI 10.5009/gnl.2013.7.6.739↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tae Jun Song · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Seong‐Hun Kim · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Jun‐Ho Choi · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Sung Woo Ko · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Sang Hyub Lee · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Jai Hoon Yoon · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Jae Hee Cho · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Seung Bae Yoon · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Dong‐Wan Seo · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Chang Min Cho · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Jong Jin Hyun · 3 shared papers, 2013–2016 · strength 0.14
- Paper Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotini… DOI 10.4251/wjgo.v8.i7.555↗
- Paper Rare case of pancreatic cancer with leptomeningeal carcinomatosis. DOI 10.3748/wjg.v21.i3.1020↗
- Paper Expression of heat shock protein 70 modulates the chemoresponsiveness of pancreatic cancer. DOI 10.5009/gnl.2013.7.6.739↗
- Yoon Tae Jeen · 3 shared papers, 2013–2016 · strength 0.14
- Paper Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotini… DOI 10.4251/wjgo.v8.i7.555↗
- Paper Rare case of pancreatic cancer with leptomeningeal carcinomatosis. DOI 10.3748/wjg.v21.i3.1020↗
- Paper Expression of heat shock protein 70 modulates the chemoresponsiveness of pancreatic cancer. DOI 10.5009/gnl.2013.7.6.739↗
- Jae Min Lee · 2 shared papers, 2015–2016 · strength 0.10
- Chang Duck Kim · 2 shared papers, 2013–2016 · strength 0.09
- In Kyung Yoo · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.